B-Cell non-Hodgkin's lymphoma in children and adolescents: surface antigen expression and clinical implications for future targeted bioimmune therapy: a children's cancer group report.
about
Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and FutureRituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice.A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment.
P2860
B-Cell non-Hodgkin's lymphoma in children and adolescents: surface antigen expression and clinical implications for future targeted bioimmune therapy: a children's cancer group report.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
B-Cell non-Hodgkin's lymphoma ...... hildren's cancer group report.
@en
type
label
B-Cell non-Hodgkin's lymphoma ...... hildren's cancer group report.
@en
prefLabel
B-Cell non-Hodgkin's lymphoma ...... hildren's cancer group report.
@en
P2093
P1476
B-Cell non-Hodgkin's lymphoma ...... hildren's cancer group report.
@en
P2093
Mark A Lones
Mitchell S Cairo
Sherrie L Perkins
Virginia Davenport
P304
P577
2003-05-01T00:00:00Z